Lahore CanSino vaccine trial concludes with no severe reactions reported
Most participants developed antibodies to coronavirus SAMAA | Daniyal Umer - Posted: Jan 23, 2021 | Last Updated: 3 months ago SAMAA | Daniyal Umer Posted: Jan 23, 2021 | Last Updated: 3 months ago
Photo: SAMAA TV screengrab
Listen to the story
The trial of a coronavirus vaccine from China s CanSino Biologics has been successfully completed at Lahoreâs University of Health Sciences. No severe reactions have been reported.
Only 5% of those vaccinated experienced a mild fever after being administered the shots, according to UHS Vice Chancellor Professor Javed Akram.Â
Clinical trials of the same vaccine recorded no severe adverse effects as well, CanSinoâs Chief Scientific Officer Zhu Tao said in September 2020.
Pakistani medical students demand promotion to next semester
Question the fairness of exams amid the virus pandemic SAMAA | Web desk - Posted: Jan 2, 2021 | Last Updated: 3 months ago SAMAA | Web desk Posted: Jan 2, 2021 | Last Updated: 3 months ago
Photo: SAMAA Digital
Pakistani medical students demanded on Friday their promotion to the next academic semester immediately.
They cited rising numbers of Covid-19 cases among students and an incomplete delivery of the curriculum, questioning the fairness of exams amid the pandemic.
Students enrolled in the MBBS and BDS programmes at various colleges in Sindh, Punjab and Khyber Pakhtunkhwa objected to physical exams and called for them to be held online.